At SciBase we are on a mission to ensure proactive skin health management and early detection of skin cancer and skin disorders. We are experiencing continued growth in Europe, with profitable sales growth in Germany and expansion into new markets, including Italy. We proudly hold MDR certification in Europe which decreases the barrier to entry for competitors. Our presence in the U.S. market holds immense growth potential and with a new organization on site we saw a broadened customer base and a 222% increase in sales. SciBase is currently the only company with approved products using EIS and AI for assessment of skin cancer and skin barrier function, and in the U.S. Nevisense is the only point-of-care product available for melanoma detection.